Marketing and License AgreementMarketing and License Agreement • November 3rd, 2004 • Cephalon Inc • Pharmaceutical preparations
This Marketing and License Agreement (this “Agreement”) is made and shall be effective as of February 24, 2000 by and among Kyowa Hakim Kogyo Co., Ltd., a Japanese corporation with its principal place of business located at 1-6-1 Ohtemachi, Chiyoda-ku, Tokyo 100-8185, Japan (hereinafter referred to as “Kyowa”), H. Lundbeck A/S, a Danish corporation with its principal place of business located at 9 Ottiliavej, DK-2S00 Valby, Copenhagen, Denmark (hereinafter referred to as “Lundbeck”), and Cephalon, Inc., a Delaware corporation with its principal place of business located at 145 Brandywine Parkway, West Chester, Pennsylvania 19380-4245, U.S.A. (hereinafter referred to as “Cephalon”).
Amendment No.2 To Joint Research, Development and License Agreement dated May 28, 1999 made between Cephalon Inc. West Chester Pennsylvania 19380-4245 andJoint Research, Development and License Agreement • November 3rd, 2004 • Cephalon Inc • Pharmaceutical preparations
March 16, 2000Joint Research, Development and License Agreement • November 3rd, 2004 • Cephalon Inc • Pharmaceutical preparations
This will serve to clarify certain aspects of the Joint Research, Development and License Agreement between Cephalon, Inc (“Cephalon”) and H Lundbeck A/S (“Lundbeck”) dated May 28, 1999 (the “Agreement”). All terms and conditions not otherwise defined or modified herein shall remain in full force and effect as set forth In the Agreement.
